Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-23-000033

SVP Corporate Strategy-Develop sold 226 shares at $114.40 ($25,854)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Dolan Matthew Vincent SVP Corporate Strategy-Develop 2023-03-06 Sale −226 $114.40 $25,854 26,536 D
Open-market sales · 226 sh · avg $114.40 · $25,854
Loading xslF345X03/edgardoc.xml…